119 related articles for article (PubMed ID: 37093849)
21. Expression of serum miR-218 in hepatocellular carcinoma and its prognostic significance.
Yang L; Xu Q; Xie H; Gu G; Jiang J
Clin Transl Oncol; 2016 Aug; 18(8):841-7. PubMed ID: 26586116
[TBL] [Abstract][Full Text] [Related]
22. A novel necroptosis-associated miRNA signature predicting prognosis of endometrial cancer and correlated with immune infiltration.
Ye Z; Jiang Y; Wu J
Taiwan J Obstet Gynecol; 2023 Mar; 62(2):291-298. PubMed ID: 36965898
[TBL] [Abstract][Full Text] [Related]
23. Screening microRNAs as potential prognostic biomarkers for lung adenocarcinoma.
Dai H; Li L; Yang Y; Chen H; Dong X; Mao Y; Gao Y
Ann Med; 2023; 55(2):2241013. PubMed ID: 37930873
[TBL] [Abstract][Full Text] [Related]
24. Circulating miR-199a-3p in plasma and its potential diagnostic and prognostic value in glioma.
Chai C; Song LJ; Yang B; Han SY; Li XQ; Li M
Eur Rev Med Pharmacol Sci; 2016 Dec; 20(23):4885-4890. PubMed ID: 27981547
[TBL] [Abstract][Full Text] [Related]
25. miR-199a-3p and miR-214-3p improve the overall survival prediction of muscle-invasive bladder cancer patients after radical cystectomy.
Ecke TH; Stier K; Weickmann S; Zhao Z; Buckendahl L; Stephan C; Kilic E; Jung K
Cancer Med; 2017 Oct; 6(10):2252-2262. PubMed ID: 28879675
[TBL] [Abstract][Full Text] [Related]
26. Serum MicroRNA-370 as a potential diagnostic and prognostic biomarker for pediatric acute myeloid leukemia.
Lin X; Wang Z; Wang Y; Feng W
Int J Clin Exp Pathol; 2015; 8(11):14658-66. PubMed ID: 26823789
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic and prognostic significance of serum miR-24-3p in HBV-related hepatocellular carcinoma.
Meng FL; Wang W; Jia WD
Med Oncol; 2014 Sep; 31(9):177. PubMed ID: 25129312
[TBL] [Abstract][Full Text] [Related]
28. Distinct power of bone marrow microRNA signatures and tumor suppressor genes for early detection of acute leukemia.
Memari F; Tavakolpour V; Mohajeri N; Poopak B; Fallah P; Alizadeh E; Kouhkan F; Zarghami N
Clin Transl Oncol; 2022 Jul; 24(7):1372-1380. PubMed ID: 35247197
[TBL] [Abstract][Full Text] [Related]
29. MiR-128-3p as blood based liquid biopsy biomarker in childhood acute lymphoblastic leukemia.
Rzepiel A; Horváth A; Kutszegi N; Gézsi A; Sági JC; Almási L; Egyed B; Lőrincz P; Visnovitz T; Kovács GT; Szalai C; Semsei ÁF; Erdélyi DJ
Mol Cell Probes; 2023 Feb; 67():101893. PubMed ID: 36640912
[TBL] [Abstract][Full Text] [Related]
30. Comparison of minimal residual disease (MRD) monitoring by WT1 quantification between childhood acute myeloid leukemia and acute lymphoblastic leukemia.
Zhang R; Yang JY; Sun HQ; Jia H; Liao J; Shi YJ; Li G
Eur Rev Med Pharmacol Sci; 2015; 19(14):2679-88. PubMed ID: 26221900
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic and prognostic implications of a serum miRNA panel in oesophageal squamous cell carcinoma.
Wu C; Wang C; Guan X; Liu Y; Li D; Zhou X; Zhang Y; Chen X; Wang J; Zen K; Zhang CY; Zhang C
PLoS One; 2014; 9(3):e92292. PubMed ID: 24651474
[TBL] [Abstract][Full Text] [Related]
32. Circ_0000745 promotes acute lymphoblastic leukemia progression through mediating miR-494-3p/NET1 axis.
Yang X; Li Y; Zhang Y; Liu J
Hematology; 2022 Dec; 27(1):11-22. PubMed ID: 34957935
[TBL] [Abstract][Full Text] [Related]
33. [Expression and Clinical Significance of Serum MiR-370 and MiR-203 in Patients with Acute Myeloid Leukemia].
Ye LH; Ma X; Xu SC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Apr; 29(2):445-449. PubMed ID: 33812413
[TBL] [Abstract][Full Text] [Related]
34. Expression of miR-652-3p and Effect on Apoptosis and Drug Sensitivity in Pediatric Acute Lymphoblastic Leukemia.
Jiang Q; Lu X; Huang P; Gao C; Zhao X; Xing T; Li G; Bao S; Zheng H
Biomed Res Int; 2018; 2018():5724686. PubMed ID: 29967774
[TBL] [Abstract][Full Text] [Related]
35. [Expression and clinical significance of microRNA-21-3p and microRNA-551-5p in patients with acute pancreatitis].
Wu K; Wang L; Fu G; Zheng Y
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Apr; 32(4):463-467. PubMed ID: 32527354
[TBL] [Abstract][Full Text] [Related]
36. Serum microRNA expression signatures as novel noninvasive biomarkers for prediction and prognosis of muscle-invasive bladder cancer.
Jiang X; Du L; Duan W; Wang R; Yan K; Wang L; Li J; Zheng G; Zhang X; Yang Y; Wang C
Oncotarget; 2016 Jun; 7(24):36733-36742. PubMed ID: 27167342
[TBL] [Abstract][Full Text] [Related]
37. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.
Zhou X; Lu Z; Wang T; Huang Z; Zhu W; Miao Y
Gene; 2018 Oct; 673():181-193. PubMed ID: 29913239
[TBL] [Abstract][Full Text] [Related]
38. A four serum-miRNA panel serves as a potential diagnostic biomarker of osteosarcoma.
Huang C; Wang Q; Ma S; Sun Y; Vadamootoo AS; Jin C
Int J Clin Oncol; 2019 Aug; 24(8):976-982. PubMed ID: 31111286
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA as a diagnostic biomarker in childhood acute lymphoblastic leukemia; systematic review, meta-analysis and recommendations.
Rashed WM; Hammad AM; Saad AM; Shohdy KS
Crit Rev Oncol Hematol; 2019 Apr; 136():70-78. PubMed ID: 30878131
[TBL] [Abstract][Full Text] [Related]
40. [Expression of MiR-429 in Patients with Acute Lymphoblastic Leukemia and Its Prognostic Value].
Zhang LC; Zhong C; Ma YJ; Liu M; Nong WX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb; 28(1):119-124. PubMed ID: 32027263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]